A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions

Increasing amounts of systems toxicology data, including omics results, are becoming publically available and accessible in databases. Data-driven and informatics-tool supported pipeline schemas for fitting such data into Adverse Outcome Pathway (AOP) descriptions could potentially aid the development of nonanimal-based hazard and risk assessment methods. We devised a 6-step workflow that integrated diverse types of toxicology data into a novel AOP scheme for pulmonary fibrosis. Mining of literature references and diverse data sources covering previous pathway descriptions and molecular results were coupled in a stepwise manner with informatics tools applications that enabled gene linkage and pathway identification in molecular interaction maps. Ultimately, a network of functional elements coupled 64 pulmonary fibrosis-associated genes into a novel, open-source AOP-linked molecular pathway, now available for commenting and improvements in WikiPathways (WP3624). Applying in silico-based knowledge extraction and modeling, the pipeline enabled screening and fusion of many different complex data types, including the integration of omics results. Overall, the taken, stepwise approach should be generally useful to construct novel AOP descriptions as well as to enrich developing AOP descriptions in progress.

[1]  Krister Wennerberg,et al.  A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury , 2017, Nature Communications.

[2]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[3]  Ola Spjuth,et al.  Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of ‘Omics’ Data from Human Cell Cultures , 2015, Alternatives to laboratory animals : ATLA.

[4]  Ali Emad,et al.  Relationship Between Eosinophilia and Levels of Chemokines (CCL5 and CCL11) and IL-5 in Bronchoalveolar Lavage Fluid of Patients With Mustard Gas-Induced Pulmonary Fibrosis , 2007, Journal of Clinical Immunology.

[5]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[6]  Chris T. A. Evelo,et al.  Presenting and exploring biological pathways with PathVisio , 2008, BMC Bioinformatics.

[7]  Jie Dong,et al.  Advances in mechanisms and signaling pathways of carbon nanotube toxicity , 2015, Nanotoxicology.

[8]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[9]  Dongmei Wu,et al.  Transcriptomic Analysis Reveals Novel Mechanistic Insight into Murine Biological Responses to Multi-Walled Carbon Nanotubes in Lungs and Cultured Lung Epithelial Cells , 2013, PloS one.

[10]  Denis Wirtz,et al.  Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by Inducing P4HA1, P4HA2, and PLOD2 Expression in Fibroblasts* , 2013, The Journal of Biological Chemistry.

[11]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[12]  Ali Emad,et al.  Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[13]  Chris T. A. Evelo,et al.  The BridgeDb framework: standardized access to gene, protein and metabolite identifier mapping services , 2010, BMC Bioinformatics.

[14]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[15]  Yong Qian,et al.  mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..

[17]  Raymond R Tice,et al.  Intersection of toxicogenomics and high throughput screening in the Tox21 program: an NIEHS perspective. , 2016, International journal of biotechnology.

[18]  Georgia Tsiliki,et al.  The eNanoMapper database for nanomaterial safety information , 2015, Beilstein journal of nanotechnology.

[19]  Dominique Lison,et al.  Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP) , 2015, Particle and Fibre Toxicology.

[20]  Carlo Vancheri,et al.  Common pathways in idiopathic pulmonary fibrosis and cancer , 2013, European Respiratory Review.

[21]  Nianqiang Wu,et al.  Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. , 2010, Toxicology.

[22]  N. Todd,et al.  Molecular and cellular mechanisms of pulmonary fibrosis , 2012, Fibrogenesis & tissue repair.

[23]  David Allen,et al.  Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials , 2016, Archives of Toxicology.

[24]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[25]  D BurgoonLyle,et al.  The AOPOntology: A Semantic Artificial Intelligence Tool for Predictive Toxicology , 2017 .

[26]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[27]  Jennifer Park,et al.  Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems , 2015, Database J. Biol. Databases Curation.

[28]  I. Laher,et al.  Systems Biology of Free Radicals and Antioxidants , 2014 .

[29]  A. Churg,et al.  Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.

[30]  Melvin E. Andersen,et al.  Developing tools for defining and establishing pathways of toxicity , 2015, Archives of Toxicology.

[31]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[32]  Ryan Miller,et al.  WikiPathways: capturing the full diversity of pathway knowledge , 2015, Nucleic Acids Res..

[33]  Andrew Worth,et al.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). , 2014, Regulatory toxicology and pharmacology : RTP.

[34]  Albert Duschl,et al.  The Significance and Insignificance of Carbon Nanotube-Induced Inflammation , 2014 .

[35]  Ralf Herwig,et al.  Analyzing and interpreting genome data at the network level with ConsensusPathDB , 2016, Nature Protocols.

[36]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[37]  Melvin E. Andersen,et al.  Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  C. Taylor,et al.  Hypoxia-sensitive pathways in inflammation-driven fibrosis. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  Blanca Suarez-Merino,et al.  High throughput toxicity screening and intracellular detection of nanomaterials , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[40]  Thomas Hartung,et al.  Making big sense from big data in toxicology by read-across. , 2016, ALTEX.

[41]  Janine Ezendam,et al.  Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data , 2014, Critical reviews in toxicology.

[42]  Mathieu Vinken,et al.  The adverse outcome pathway concept: a pragmatic tool in toxicology. , 2013, Toxicology.

[43]  Ralf Herwig,et al.  The ConsensusPathDB interaction database: 2013 update , 2012, Nucleic Acids Res..

[44]  Georgia Tsiliki,et al.  Enriching Nanomaterials Omics Data: An Integration Technique to Generate Biological Descriptors , 2017 .

[45]  Scott C. Wesselkamper,et al.  Editor's Highlight: Application of Gene Set Enrichment Analysis for Identification of Chemically Induced, Biologically Relevant Transcriptomic Networks and Potential Utilization in Human Health Risk Assessment , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  Yong Qian,et al.  Multi-walled carbon nanotube-induced gene expression in vitro: concordance with in vivo studies. , 2015, Toxicology.

[47]  Yong Qian,et al.  System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses. , 2013, Toxicology and applied pharmacology.

[48]  Don C Rockey,et al.  Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.

[49]  Andrew Williams,et al.  Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes , 2015, Particle and Fibre Toxicology.

[50]  Thomas C. Wiegers,et al.  Advancing Exposure Science through Chemical Data Curation and Integration in the Comparative Toxicogenomics Database , 2016, Environmental health perspectives.

[51]  Nuno Nunes,et al.  PathVisio 3: An Extendable Pathway Analysis Toolbox , 2015, PLoS Comput. Biol..

[52]  Joyce K. Thompson,et al.  Asbestos-Induced Oxidative Stress in Lung Pathogenesis , 2014 .

[53]  Melvin E Andersen,et al.  Adverse Outcome Pathways can drive non-animal approaches for safety assessment , 2015, Journal of applied toxicology : JAT.

[54]  Yong Qian,et al.  Multiwalled carbon nanotube-induced pulmonary inflammatory and fibrotic responses and genomic changes following aspiration exposure in mice: A 1-year postexposure study , 2016, Journal of toxicology and environmental health. Part A.

[55]  T. Oury,et al.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.